Biotech is going to be eaten by software, that's not in question. It's clear that Kleiner lost their first bet on health startups, which means that I'm looking forward to seeing the next batch of startups give it a go.

"It's clear that Kleiner lost their first bet on health startups" - What do you mean by this?

No doubt, biotech will be "eaten" by software. But the crowded market of biotech software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies.

Yet, I don't see much evidence of growth. Looks like 'play money' for investors.

You could have said all these things about Dropbox.

"The crowded market of backup software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies."

True, but Dropbox started from winning geeky hearts - and there are far more geeks than gainfully employed biologists.

I am open to sharing ideas offline - and rich experiences on why the ones that tried have not succeeded so far.

Good comment anyway.

Congrats to Benchling! They're a phenomenal group of guys who are really going to do great things.